Ember Therapeutics Garners $34,000,000 Series A Funding

  • Feed Type
  • Date
    12/15/2011
  • Company Name
    Ember Therapeutics
  • Mailing Address
    29 Newbury Street Boston, MA 02116
  • Company Description
    Ember Therapeutics is a product-focused company translating its world-class biology in the emerging area of brown fat and recent breakthroughs in understanding the mechanisms of selective insulin sensitivity into a proprietary pipeline of peripherally-acting treatments for metabolic disease, including Type 2 diabetes and obesity.
  • Website
    http://www.embertx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $34,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Third Rock Ventures, LLC today announced the formation of Ember Therapeutics. The company was launched with a $34 million Series A financing.
  • M&A Terms
  • Venture Investor
    Third Rock Ventures

By posting a comment, you agree to our terms and conditions.